Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Repronex: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Repronex - General Information

Mixture of luteinizing hormone and follicle stimulating hormone extracted from the urine of postmeonopausal women. Composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues

 

Pharmacology of Repronex

Used to treat female infertility, Repronex stimulates late follicular maturation and resumption of oocyte meiosis, and initiates rupture of the pre-ovulatory ovarian follicle. Repronex bind to the LH/hCG/FSH receptor of the granulosa and theca cells of the ovary to effect these changes in the absence of an endogenous LH surge.

 

Repronex for patients

Prior to therapy with Repronex®, patients should be informed of the duration of treatment and the monitoring of their condition that will be required. Possible adverse reactions and the risk of multiple births should also be discussed.

 

Repronex Interactions

 

Repronex Contraindications

Repronex is contraindicated in women who have:

1. A high FSH level indicating primary ovarian failure.

2. Uncontrolled thyroid and adrenal dysfunction.

3. An organic intracranial lesion such as a pituitary tumor.

4. The presence of any cause of infertility other than anovulation unless they are candidates for in vitro- fertilization.

5. Abnormal bleeding of undetermined origin.

6. Ovarian cysts or enlargement not due to polycystic ovary syndrome.

7. Prior hypersensitivity to menotropins.

8. Repronex is not indicated in women who are pregnant. There are limited human data on the effects of menotropins when administered during pregnancy.

 

Additional information about Repronex

Repronex Indication: For treatment of female infertility Mechanism Of Action: Repronex bind to the Follicle stimulating hormone receptor which results in ovulation in the absence of sufficient endogenous Luteinizing hormone. Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Menotropins Synonyms: LH-B; LSH- beta; LSH-B; Luteinizing hormone beta subunit; Lutropin beta chain precursor Drug Category: Fertility Agents Drug Type: Biotech; Approved Other Brand Names containing Menotropins: Repronex; Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Not Available Half Life: Not Available Dosage Forms of Repronex: Powder, for solution SubcutaneousPowder, for solution Intramuscular Chemical IUPAC Name: Not Available Chemical Formula: C1014H1609N287O294S27 Menotropins on Wikipedia: https://en.wikipedia.org/wiki/Menotropins Organisms Affected: Humans and other mammals